Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.
about
Celiac disease and non-celiac gluten sensitivityImproving outcomes of refractory celiac disease - current and emerging treatment strategiesCoeliac disease in the 21st century: paradigm shifts in the modern age.Diversity of the cultivable human gut microbiome involved in gluten metabolism: isolation of microorganisms with potential interest for coeliac disease.Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa.Biomarkers to Monitor Gluten-Free Diet Compliance in Celiac Patients.The management of refractory coeliac disease.Generation of food-grade recombinant Lactobacillus casei delivering Myxococcus xanthus prolyl endopeptidase.A celiac cellular phenotype, with altered LPP sub-cellular distribution, is inducible in controls by the toxic gliadin peptide P31-43Detection of specific IgA antibodies against a novel deamidated 8-Mer gliadin peptide in blood plasma samples from celiac patientsImmunogenetic Pathogenesis of Celiac Disease and Non-celiac Gluten Sensitivity.Tests for Serum Transglutaminase and Endomysial Antibodies do not Detect Most Patients With Celiac Disease and Persistent Villous Atrophy on Gluten-free Diets: a Meta-analysis.Recent Advances in Celiac Disease from TTG to Gluten in Pee.Fecal Gluten Peptides Reveal Limitations of Serological Tests and Food Questionnaires for Monitoring Gluten-Free Diet in Celiac Disease Patients.Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet.Detection of gluten immunogenic peptides in the urine of patients with coeliac disease reveals transgressions in the gluten-free diet and incomplete mucosal healing.Endocytosis and transcytosis of gliadin peptides.Long-term care for patients with coeliac disease in the UK: a review of the literature and future directions.Celiac disease: understanding the gluten-free diet.Challenges in gluten-free diet in coeliac disease: Prague consensus.Differences in gluten metabolism among healthy volunteers, coeliac disease patients and first-degree relatives.The human digestive tract has proteases capable of gluten hydrolysis.Comparison of R5 and G12 Antibody-Based ELISA Used for the Determination of the Gluten Content in Official Food Samples.Immunological determination of gliadin 33-mer equivalent peptides in beers as a specific and practical analytical method to assess safety for celiac patients.Topical Review: Adherence Interventions for Youth on Gluten-Free Diets.Plasma Alkylresorcinols Reflect Gluten Intake and Distinguish between Gluten-Rich and Gluten-Poor Diets in a Population at Risk of Metabolic Syndrome.Serum alkylresorcinols as biomarkers of dietary gluten exposure in coeliac disease.
P2860
Q22306535-B57F8384-60DF-41F3-B11A-0267B4602C59Q26740769-EFFD39D3-62AA-44EA-9E20-C0455E99DCC8Q30235526-A039F0E2-34B5-405A-9F5D-7C8E3B26BFF4Q31150648-366A48E9-39B0-4A98-8469-9F760DBF4D3AQ34447313-647A706F-FA83-4BAF-9DA6-D84407DBEA22Q34548810-D053669B-B106-44BD-ADA7-7CEC8B3CF588Q34650083-44D519B8-33AA-44E1-94F5-C5238F16DC5AQ34661417-C2E488F4-8059-4CF6-A139-4FDF1384CF37Q35053254-8826A2B2-FEB4-49BE-B23D-1EB961FDB05DQ35053807-DA9ADB6D-90FA-4662-B4C3-DB2838961FD3Q36027518-FAAB3A3A-B911-4676-A2A3-1836F26D01CDQ36381993-2F9A8B18-32B0-4524-BCAC-D4971C3921B2Q36755761-8744CE4B-DA6A-4DB4-8872-8EA59FC4D5FFQ37330452-7AC1BB80-31CF-404D-8BF1-507CBA2C0568Q37616424-BC7D08EA-5794-48CF-8222-A708A98957B1Q37617069-252124A4-6D09-4646-8E8B-5E7DFD1F429CQ38515571-D917A656-1631-4615-831B-B288DA9CF887Q38838366-1840F50E-A08E-4C5F-829D-7A2E268A6FD9Q38873776-921E3D7A-C0E0-4F21-B92B-19513BCD88DEQ39215696-B7FC50FA-48BB-46E7-835D-DF1CE064335EQ40476432-DBBE2D99-1BDD-41E7-A677-0D921155E401Q41038260-4CAECF59-3DDA-441E-AA2C-9A49430BFAF9Q41149064-FCC2277E-C76F-4F95-9020-CEE9222D34E6Q46138568-84D8C537-CFFA-40E6-8290-B81437855719Q47863580-5297F432-3C1E-410E-9C1B-0C2E7FC9DC91Q48054588-0D53ECD2-5049-497B-95A8-CA0A501F52D2Q51061237-5C612929-75EA-418A-87BA-382F3B8EC27A
P2860
Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@ast
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@en
type
label
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@ast
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@en
prefLabel
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@ast
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@en
P2093
P2860
P356
P1476
Monitoring of gluten-free diet ...... equivalent epitopes in feces.
@en
P2093
Alberto Caminero
Alfonso Rodríguez-Herrera
Angel Cebolla
Carolina Sousa
Esther Nistal
Isabel Comino
Javier Casqueiro
Miguel Ángel Síglez
Santiago Vivas
P2860
P304
P356
10.3945/AJCN.111.026708
P407
P577
2012-01-18T00:00:00Z